Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04557098
Title A Study of Teclistamab, in Participants With Relapsed or Refractory Multiple Myeloma
Acronym MajesTEC-1
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.